Baricitinib and Sotrovimab drugs recommended by WHO

  • IASbaba
  • January 17, 2022
  • 0
UPSC Articles
Print Friendly, PDF & Email

Baricitinib and Sotrovimab drugs recommended by WHO

Part of: Prelims and GS-II Health and GS-III Sci and tech

Context The World Health Organization (WHO) has recommended two drugs, baricitinib and sotrovimab, for treatment of Covid-19.

About Baricitinib

  • Baricitinib is also used to treat rheumatoid arthritis.
  • It is an oral drug
  • It has now been “strongly recommended” for patients with severe or critical Covid-19 in combination with corticosteroids.
  • It is part of a class of drugs called Janus kinase (JAK) inhibitors that suppress the overstimulation of the immune system.

About Sotrovimab

  • It is an investigational monoclonal antibody for use in treating conditions caused by coronavirus.
  • The WHO has conditionally recommended its use for treating mild or moderate Covid-19 in patients who are at high risk of hospitalisation.

News Source: IE

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates